Firstly, we have found that the use of a wide ABC inhibitor—i.e., cyclosporine A (20 μM)—increases antiproliferative activity of RSV as compared to the control in SW480 colorectal cancer cells. This evidence concerns the gene ABCB6 and colorectal cancer.